2016 north american veterinary regen erative medicine ... · cell use in oa clinical research...

November 17 – 20, 2016

omNi AmeliA islANd PlANtAtioN

chANNel islANds, floridA

2016 North AmericAN veteriNAry regeNerAtive

mediciNe Conference

2

Your Partner in regenerative Medicine

Science and evidence based medical solutions

• 13 peer-reviewed publications and book chapters• Randomized blinded clinical studies to support medical decisions• Cell yield and viability determined to ensure accurate dosing every treatment

Fda

• Working with the FDA Center for Veterinary Medicine since 2003• Procedures in autologous lab consistent with FDA GTP guidelines• 3 Investigational New Drug Applications filed with FDA (INAD) • GMP manufacturing facility for INAD products

continuing education Partner

• Veterinary consultants for Equine and Small Animal cases• First RACE-approved Regenerative Medicine CE for veterinarians and staff• Over 4,000 clinicians trained

Since 2002 and into the Future

• 100% animal health focused• Over 12,000 animals provided with stem cell services• Exclusive license rights to over 70 patents• Committed to deliver multiple FDA approved off-the-shelf stem cell products in the

near future

Stop by our booth in the Partner Pavilion to find out the latest in Regenerative Medicine. Pick up a copy of our Latest Peer Reviewed Paper on Canine Allogeneic Adipose Stem Cell use in OA Clinical Research Summary for Stem Cell Therapy for EIPH.

vetStem Biopharma 12860 Danielson Court. Suite B. Poway, CA 92064

858-748-2004 | www.vetstem.com

2016 North AmericAN VeteriNAry regeNerAtiVe mediciNe coNfereNce

4

Dear Colleagues,

Welcome to the 2016 NAVRMA Conference, and thank you for supporting the North American Veterinary

Regenerative Medicine Association.

NAVRMA held its inaugural conference in California in 2010. Since then it has held meetings in most parts

of the country and we are pleased to now be back on the lower eastern seaboard. The organization was

formed through the efforts and dedication of members of the UC Davis Center for Equine Health, Alamo

Pintado Equine Medical Center and Rood and Riddle Equine Hospital. Six years later, we have returned to

the warm south with a broad range of support, including industry leaders in regenerative medicine and

biomedical imaging, veterinary foundations, generous donors with an interest in regenerative medicine,

and experts in regulation of regenerative medicine and intellectual property protection.

Our dedication to the partnership between the science and practice of veterinary regenerative medicine

to better the health and lives of veterinary patients is clear in this conference program that showcases the

development of new technologies for treating injury and disease in veterinary patients, the discovery of new

targets in regenerative therapies, sharing results of rigorous studies to validate efficacy of these cutting edge

strategies, education of veterinarians on new techniques on the horizon, and a discussion of unmet clinical

needs. Our organization seeks to foster these goals, within a collaborative and engaging environment.

The scientific program is designed to introduce the concepts and definitions of regenerative medicine

on Friday morning, with an opening inaugural address from preeminent regenerative scientist Dr Arnold

Caplan. This will be followed by basic science concepts and evidence-based clinical applications Friday

afternoon and Saturday. Saturday afternoon will highlight the clinical overview and new solutions to old

problems. We will conclude our conference with the latest developments in regulatory and commercial

aspects of veterinary regenerative medicine on Sunday, including a final clinical session and a late-breaking

abstract group to highlight clinical research that represents the cutting edge for regenerative medicine.

We chose Amelia Island as the location for this year’s conference because of its beautiful setting and local

activities such as golf, tennis, water sports and local wildlife. The closed environment of the resort should

foster new friendships and allow collaborations and opportunities to develop.

Above all, NAVRMA hopes that the promise for a cure that regenerative medicine offers becomes a reality

for dogs, cats, horses, and other veterinary species, and that our organization enables development of

treatments through its efforts to foster education and collaboration.

We hope you enjoy your time at the Omni Resort on Amelia Island learning about the new advances being

made in our field.

Sincerely,

Alan J Nixon, BVSc, MS

Chair, NAVRMA

Welcome

5

NOVEMBER 17–20, 2016 OMNI AMELIA ISLAND PLANTATION

tAble of coNteNts

Schedule At-a-Glance ...................................................................................................................................6

Conference Schedule Friday, November 18 .......................................................................................... 7

Conference Schedule Saturday, November 19 .....................................................................................8

Conference Schedule Sunday, November 20 .......................................................................................9

Keynote Speaker ........................................................................................................................................... 10

Invited Speakers .......................................................................................................................................10-13

NAVRMA Sponsors ..................................................................................................................................14-17

Board of Directors ........................................................................................................................................23


6

schedule At-a-GlanceTHURSDAY

6:00 pm – 9:00 pm Registration Open

6:00 pm – 9:00 pm Board of Directors Meeting

FRIDAY

7:00 am – 5:00 pm Registration Open

7:00 am – 8:30 am Coffee & Tea

8:30 am – 10:00 am Lectures: Opening Keynote & Stem Cell Basic Science

8:30 am Keynote Speaker: Arnold Caplan

10:00 am – 10:30 am Break

10:30 am – 12:00 pm Lectures and Abstracts: Stem Cell Basic Science

12:00 pm – 1:00 pm Lunch Break

1:00 pm – 3:00 pm Lectures and Abstracts: Regenerative Medicine in Practice

3:00 pm – 3:30 pm Break

3:30 pm – 5:00 pm Abstracts: Regenerative Medicine in Practice

5:00 pm – 6:00 pm Cocktail Hour with Partners

SATURDAY


7:30 am – 8:30 am Panel: Small Animal Clinical Practice

8:30 am – 10:00 am Scientific Presentations

10:00 am – 10:30 am Break

10:30 am – 12:00 pm Scientific Presentations


1:00 pm – 3:45 pm Combined Approaches to Cell and Gene Therapy

3:45 pm – 4:30 pm Poster Session

4:30 pm – 5:30 pm Instructive Lab: “PRP: Basic Clinical Considerations,” presented by Arhrex Vet System

7:00 pm – 9:00 pm NAVRMA Banquet Dinner and Awards Presentation

SUNDAY


7:30 am – 8:30 am Panel: Large Animal Clinical Practice

8:30 am – 10:00 am Lectures: Regulatory, Business and Industry Topics

10:00 am – 10:30 am Break

10:30 am – 12:30 pm Lectures and Abstracts: Practice Application of Cell and Other Biologics in the Current

Regulatory Environment

7


Friday November 18

7:00 am – 5:00 pm Registration Open


8:30 am – 10:00 am Lectures: Opening Keynote & Stem Cell Basic Science

8:30 am Arnold Caplan Keynote: Mechanism of stem cell action: Building blocks and environmental modulators

9:30 am Thomas Koch Scaling up cell expansion

10:00 am – 10:30 am Break

10:30 am – 12:00 pm Lectures and Abstracts: Stem Cell Basic Science

10:30 am Jonn Peroni Stem cell immunomodulation: A potent impact of local stem cell therapy

11:00 am Kurt Hankenson Manipulating the stem cell environment to promote bone regeneration

11:30 am Ian Tobias Mitochondrial metabolism delineates pluripotent state conversion in canine embryonic stem cells

11:45 am Sarah Lepage Generation of osteochondral constructs using equine cord blood-derived MSCs and a calcium polyphosphate bone substrate


1:00 pm – 3:00 pm Lectures and Abstracts: Regenerative Medicine in Practice

1:00 pm Laurie Goodrich Sites of bone marrow harvest for MSC proagation

1:30 pm Tracy Webb Optimization of feline stem cell therapy: Preconditioning strategies and donor selection

2:00 pm Robert Harman A prospective, randomized, blinded and placebo-controlled efficacy study of intraarticular allogenic adipose stem cells for the treatment of osteoarthritis in dogs

2:15 pm Kristina Kiefer Comparison of various freezing medium conditions on the viability and phenotype of canine adipose-derived stromal cells

2:30 pm Stephane Maddens Neonatal MSCs as an anti-inflammatory alternative for post-surgery medical management in dogs which cannot be prescribed with NSAID

2:45 pm Rafael Senos Nandrolone decanoate improves bone repair in fracture nonunions with vascular deficit in a rat model

3:00 pm – 3:30 pm Break

3:30 pm – 5:00 pm Abstracts: Regenerative Medicine in Practice

3:30 pm Alan Nixon Combinatorial approaches to cartilage repair

4:00 pm F. Ross Rich Stifle injuries treated with regenerative therapy with or without surgery fare better and heal faster than with arthroscopic surgery alone: A study of 98 horses

4:15 pm Stephane Maddens Allogeneic MSC as treatment for horse fetlocks osteoarthritis. A random double blind clinical study

4:30 pm AniCell BioTech Industry presentation: “Amnion FAQ: Top 10 Things You Should Know About The Latest Regenerative Treatments.”

4:45 pm BioLife Solutions Industry presentation

5:00 pm – 6:00 pm Cocktail Hour with Partners


8

Saturday November 18


7:30 am – 8:30 am Panel: Small Animal Clinic

8:30 am – 10:00 am Scientific Presentations

8:30 am Susan Volk The role of the extracellular matrix in the regenerative micro-environment

9:00 am Ashlee Watts Enhanced MSC yield and propagation methods in stem cell biology

9:30 am Jennifer Barrett In vitro models of tenogenesis for evaluating stem cell therapies

10:00 am – 10:30 am Break

10:30 am – 12:00 pm Scientific Presentations

10:30 am Maria Naskou Equine platelet lysate regulates the expression of lipopolysaccharide-induced inflammatory cytokines released by equine monocytes

10:45 am Kate Birdwhistell Effects of calcium chloride, thrombin, and freezing on growth factor concentrations and platelet activation in canine platelet-rich plasmas

11:00 am Kyla Ortved Immunomodulation of the post-traumatic joint using interleukin-10

11:30 am Stephane Maddens Supernatant from canine placenta-derived MSC exert immunomodulatory effects

11:45 am Merrilee Thorensen Modeling and therapy of exuberant granulation tissue (EGT) injury in horses


1:00 pm – 3:30 pm Combined Approaches to Cell and Gene Therapy

1:00 pm Wayne McIlwraith Cells, matrices, genes: What is the best formula for cartilage repair?

1:30 pm John Peroni Techniques for cell tracking and homing

2:00 pm Alan Nixon Vascular delivery of cells: Intaarterial versus regional intravenous

2:30 pm Madhu Dhar Xenogenic implantation of goat and equine MSCs in rat unicortical and subchondral bone defects

2:45 pm Ashlee Watts MicroRNA-29a In equine tendinopathy: A translational target

3:00 pm Alicia Bertone Novel point-of-care regenerative therapies from autologous platelet concentration and bone marrow (MSCs)

3:15 pm Alexandra Scharf MRI-based assessment of MSC therapy and healing in an ovine model of tendonitis

3:30 pm Elanco Industry Presentation: “Future Trends in Regenerative Medicine”

3:45 pm – 4:30 pm Poster Session

4:30 pm – 5:30 pm Instructive Lab: “PRP: Basic Clinical Considerations,” presented by Arhrex Vet Systems

7:00 pm – 9:00 pm NAVRMA Banquet Dinner and Awards Presentation

9


Sunday November 19


7:30 am – 8:30 am Panel: Large Animal Clinic Practice

8:30 am – 10:00 pm Lectures: Regulatory, Business and Industry Topics

8:30 am Lynn Boxer FDA: Update on cell-based products for animal use

9:00 am Karl Nobert Translational regenerative medicine: The regulatory bridge between preclinical animal data and first-in-human clinical trials

9:30 am VetStem Biopharma Industry presentation: “Evolution of evidence and regulations in veterinary regenerative medicine”

10:00 am – 10:30 am Break

10:30 am – 12:00 pm Lectures and Abstracts: Practice Application of Cell and Other Biologics in

the Current Regulatory Environment

10:30 am Kate Birdwhistell The effect of platelet rich plasma on osseous healing in dogs undergoing tibial plateau leveling osteotomy (TPLO)

10:45 am Alix Berglund In vivo immunogenicity of MHC-mismatched equine bone marrow- derived mesenchymal stem cells and implications for clinical use

11:00 am Laila Begum Late-breaking submission: Interleukin-1 receptor antagonist gene delivery controls equine synovitis and lameness in the carpal chip model

11:10 am Luciana Benedetti Late-breaking submission: Case report – Treatment of five short bone articular facture cases using allogeneic adipose-derived stem cells as unique therapy on race horses

11:20 am Alix Berglund Late-breaking submission: TGF-B2 decreases surface expression of MHC I and MHC II on equine bone marrow-derived mesenchymal stromal cells

11:30 am Cara Clouse Amnion membrane products for veterinary wound care

11:45 am Robert Harman Adipose-derived stem cells given intravenously improves epistaxis and objective bronchoscopy scoring in horses with exercise- induced pulmonary hemorrhage

12:00 pm Tracy Webb Stem cell therapy for small animal GI and renal disease


10

iNvited SpeakersJennifer BarrettDr. Barrett is the Theodora Ayer Randolph Professor of Equine Surgery at Virginia Tech’s Marion duPont Scott Equine Medical Center (EMC). She received a doctorate in molecular and cell biology from Yale University in 1999, and a doctor of veterinary medicine degree from Cornell University in 2002. Dr. Barrett completed her internship in equine medicine and surgery at Rood & Riddle Equine Hospital in Lexington, Kentucky and her residency in equine surgery at the University of Illinois in Urbana. Her orthopedic postdoctoral research position was at the University of Wisconsin in Madison. Dr. Barrett joined the Marion duPont Scott Equine Medical Center’s faculty in August 2007 and achieved Diplomate status through the American College of Veterinary Surgeons in 2008 and the American College of Veterinary Sports Medicine and Rehabilitation in 2013. She is a member of the American Veterinary Medical Association, the American Association of Equine Practitioners, Tissue Engineering and Regenerative Medicine International Society, the Veterinary Orthopedic Society and the Phi Zeta Honor Society. She is a founding director of the North American Veterinary Regenerative Medicine Association and currently serves as Chair. Her research interests include tendon, ligament, and cartilage healing, stem cell and platelet rich plasma therapies, and tissue regeneration. She

Dr. Arnold Caplan Dr. Arnold Caplan, widely regarded as “the father of the mesenchymal stem cell,” is Professor of Biology and General Medical Sciences (Oncology) and Director of the Skeletal Research Center at Case Western Reserve University, where he’s worked and taught since 1969. Dr. Caplan is a national and international scholar focusing on experimentation in the area of musculoskeletal and skin development. He has trained over 150 researchers and published over 400 papers and manuscripts. He has long been supported by the NIH and other non-profit and for-profit agencies for his efforts in trying to understand the development, maturation and aging of cartilage, bone, skin and other mesenchymal tissues and for his pioneering research

on Mesenchymal Stem Cells. Dr. Caplan has received a number of awards including the Elizabeth Winston Lanier Award given by the American Academy of Orthopaedic Surgeons as part of their 1990 Kappa Delta Awards Program, the 1999 Marshall R. Urist Award for Excellence in Tissue Regeneration Research given by the Orthopaedic Research Society, the Genzyme Lifetime Achievement Award given by the International Cartilage Repair Society in 2007, the Tissue Engineering and Regenerative Medicine International Society Inaugural Lifetime Achievement Award in 2010 and is an Inaugural Member of the “Pioneers of Innovation” chosen by the Advocacy Committee of the Orthopaedic Research Society, March 2014. Dr. Caplan received his B.S. in Chemistry at the Illinois Institute of Technology and his Ph.D. from Johns Hopkins University School of Medicine.

KeyNote Speaker

11


established the Regenerative Medicine Service at the EMC, which offers stem cell treatment and platelet rich plasma therapy to patients at the EMC and beyond. Her clinical interests include lameness, diagnostic imaging, orthopedic surgery, and emergency surgery.

Lynn Boxer Dr. Boxer obtained her veterinary degree from the Virginia-Maryland Regional College of Veterinary Medicine. After graduation, Dr. Boxer practiced equine medicine in an ambulatory practice in California before joining FDA’s Center for Veterinary Medicine. Dr. Boxer is a Veterinary Medical Officer in the Office of New Animal Drug Evaluation and is the Center lead for cell-based products at FDA’s Center for Veterinary Medicine.

Laurie Goodrich Dr. Goodrich is an Associate Professor of Equine Surgery and Lameness at Colorado State University’s College of Veterinary Medicine. She earned her DVM from the University of Illinois and then went on to complete a large animal internship at Virginia Tech and an equine surgery residency at the Marion DuPont Scott Equine Medical Center in Northern Virginia during which she also earned an MS in pharmacology. Thereafter she became board certified with the American College of Veterinary Surgery. After completing her residency, she was a surgeon at Cornell College of Veterinary Medicine for 4 years before pursuing a PhD in cartilage repair with Dr. Alan Nixon. Following completion of her PhD she became a faculty member at CSU. She currently is a clinician specializing in orthopedic diseases and is part of the team at the CSU Orthopedic Research Center. Her research focuses on regenerative medicine and gene therapy to enhance musculoskeletal healing.

Kurt HankensonDr. Hankenson is currently the Associate Director of the Laboratory for Comparative Orthopaedic Research at Michigan State University. A former equine veterinarian, he began his independent research career at the University of Michigan in 2002 as a faculty member in the Orthopaedic Research Laboratories. In 2006 he moved to the University of Pennsylvania in the School of Veterinary Medicine, where he became the inaugural holder of the Dean W. Richardson Chair for Equine Disease Research in 2012. He has a long-standing interest in musculoskeletal dysfunction and repair. In particular, his laboratory explores the molecular and cellular basis for mesenchymal stem cell osteoblast differentiation and translates these findings to clinical bone regeneration. He received his DVM from the University of Illinois (1992), an MS from Purdue University (1997), and his PhD from the University of Washington (2001).

Thomas KochDr. Koch received his DVM degree from the Veterinary College in Copenhagen, Denmark in 2000. He then worked in mixed practice before completing a one-year rotational internship in large animal medicine and surgery at the Ontario Veterinary College in 2001 to 2002. Following this, he returned to Denmark to work for one year as an equine practitioner. In 2003, he returned to the OVC to


12

become a resident in large animal medicine. He completed his residency in 2005, and has since been doing his PhD studies in Biomedical Sciences at the OVC on the topic of equine stem cells from umbilical cord blood.

Wayne McIlwraithDr. McIlwraith obtained his veterinary degree from Massey University, New Zealand, was in practice in New Zealand and the UK followed by an internship at the University of Guelph, Canada and a surgical residency at Purdue University. He also obtained MS and PhD degrees from Purdue University. Since 1979 he has been a faculty member at Colorado State University. Currently he is a University Distinguished Professor, holds the Barbara Cox Anthony University Endowed Chair in Orthopaedics and is Director of the Musculoskeletal Research Program at the Orthopaedic Research Center which is a CSU Program of Research and Scholarly Excellence. He also has a referral surgical practice in Southern California, as well as Seattle, and is a consultant and surgeon for clients in Ireland, England and France. His research interests focus on equine Orthopaedic surgery and joint disease research including novel treatments for osteoarthritis and articular cartilage repair, mesenchymal stem cell therapies and early diagnosis of osteoarthritis and pre-fracture disease using imaging and fluid biomarkers. He has authored six textbooks, 450 scientific publications and textbook chapters and given over 650 scientific presentations, seminars and workshops.

Alan Nixon Dr. Nixon is Professor of Orthopedic Surgery and Director of The Comparative Orthopaedics Laboratory and the JD&ML Wheat Orthopaedic Sports Medicine Laboratory in the College of Veterinary Medicine at Cornell University. He is also Chief Medical Officer at the Cornell University private practice Cornell Ruffian Equine Specialists in New York City. He obtained his veterinary degree from the University of Sydney in 1978 and completed a surgical residency and research degree at Colorado State University in 1983. He has held academic appointments at the University of Florida and Cornell University, where he has been a professor since 1988, serving as Chief of Surgery from 1998 to 2002. Dr. Nixon has authored over 350 papers and book chapters, and has written or co-authored two texts on equine orthopedics. Dr. Nixon’s clinical work at Cornell University focuses on musculoskeletal injury and repair, with a specific interest in regenerative medicine. Research and translational clinical application over the past three decades have included joint pathobiology and cartilage repair with cell grafting, growth factor recombinant protein and gene-enhanced chondrocyte and stem cell transplantation techniques. Dr. Nixon’s laboratory group has engaged in over 98 funded research projects including NIH and corporate funded grants with total budget expenditures of over $18 million.

John Peroni As a clinician, Dr. Peroni has treated a number of horses with musculoskeletal problems amenable to regenerative approaches including mesenchymal stem cells (MSCs) and platelet-rich plasma. Dr. Peroni has focused on the use of transduced MSCs in bone formation using an ovine fracture model, as well as the immunomodulatory effects of equine bone marrow-derived MSCs as part of an investigation into the use of allogenic stem cells for therapeutic purposes. His research includes the development

13


of immune responses following exposure of equine lymphocytes and monocytes to allogenic MSCs in attempt to understand the relations between these cells and the immune system.

Tracy Lehman Webb Dr. Webb attended Ohio State University to obtain her doctor of veterinary medicine degree (1998). She then completed a clinical internship in small animal medicine and surgery (1999) and a residency in small animal emergency and critical care (2003) at Angell Animal Medical Center in Boston, Mass. Following completion of her residency, Dr. Webb was selected as a trainee at Colorado State University for a National Institutes of Health T32 Ruth L. Kirschstein National Research Service Award (2004). Dr. Webb received a K08 Clinical Investigator Award from the National Institutes of Health National Institute of Allergy and Infectious Disease in 2007. She finished her thesis work on the modification of the innate immune response during feline immunodeficiency virus infection and received her Ph.D. in Pathology (Immunology) in 2008. Dr. Webb is currently working as a Research Scientist at CSU in the Clinical Sciences Department of the College of Veterinary Medicine and Biomedical Sciences. Her many research projects focus on two main areas: regenerative medicine/stem cell therapy and biology, and cardiovascular disease.

Susan VolkDr. Volk, V.M.D., Ph.D., Dipl. A.C.V.S. completed the Veterinary Medical Scientist Training Program at the University of Pennsylvania, receiving her veterinary degree in 1995 and her PhD for a thesis examining Bone Morphogenetic Protein signaling during endochondral ossification in 1998. Dr. Volk returned to Penn’s Veterinary School to complete a Small Animal internship and surgical residency. During that time she continued to follow her research interest in the field of adult stem cells, focusing on defining optimal inducers of osteogenesis for canine mesenchymal stem cells (MSCs). She obtained board-certification in Small Animal Surgery in 2003. Dr. Volk joined the faculty of the School of Veter-inary Medicine at the University of Pennsylvania as an Assistant Professor of Small Animal Surgery in 2007. Her research focuses on progenitor cell therapies for improving tissue repair and regeneration. Specific areas of interest include optimizing pre-delivery strategies (donor source and manipulation for maximal target cell differentiation) and methods of cellular delivery, defining regulatory cues important to direct progenitor cell homing to sites of injury, and influencing progenitor and reparative cell fate within healing tissues for use in cell-based therapeutic strategies in human and veterinary medicine.

Ashlee Watts Dr. Watts, DVM, PhD, DACVS, is director of the Comparative Orthopedics and Regenerative Medicine Lab and an equine orthopedic surgeon in the Department of Large Animal Clinical Sciences. Her clinical interest in the performance horse is a focus point for the dedicated study of orthopedic diseases and the development of innovative targeted therapeutic measures. Dr. Watts works with board certified faculty members on the Equine Orthopedics, Equine Sports Medicine & Imaging and Diagnostic Imaging services at Texas A&M and collaborates with basic scientists and veterinarians throughout the world to advance the field of equine orthopedics and regenerative medicine.


14

NAvrmA Platinum SponsorsDELAWARE NORTH

Today, Delaware North manages and provides food and beverage concessions,

premium dining, entertainment, lodging, and retail at many large venues and special

places. We set the stage for some of life’s great moments. From the first serve at the

Australian Open, to the Super Bowl kickoff, to a four-star meal at LAX, to seeing the

natural wonder of the Grand Canyon. In these moments and in millions more like them,

we’re there. We’re working behind the scenes, making each guest experience, moment,

and memory the best it can be. With operations on four continents, serving half a

billion guests a year, it’s not easy to come up with a simple phrase that captures all we

do. Yes, we’re world leaders in culinary and hospitality. We’re specialists in serving up

what fans crave, and at making travelers and visitors feel right at home. But here’s how

we’d like you to think of us. We’re a team 60,000 strong. Our role is to work behind the

scenes to create world-class experiences. And our spirit, our passion, is to go beyond

your expectations. If you are part of an organization that values a long-term partner,

we should talk. Every day, we make sure guests have unforgettable customer service

and experiences. We do this by bringing fresh thinking, a collaborative spirit, and years

of experience to every engagement. And together, we can make a difference to your

bottom line. Learn more at delawarenorth.com

ELANCO

At Elanco, we provide those who raise and care for animals with solutions that

empower them to advance a vision of food and companionship enriching life. We

understand the powerful role healthy animals play in making lives better. As pets

increasingly become important parts of our families, so too does the need to help

them live longer, healthier, higher-quality lives. As the global population grows, so too

will the need to meet the demand for safe, affordable food for all. Elanco works with

global customers, veterinarians, and industry leaders to gain key market insights that

depict current and future needs. To help ensure creativity, accountability, and quality

in meeting those needs, we employ the best scientists and pharmaceutical product

developers and structure our research and development process into four stages:

• Research and External Innovation: Identifying products or technologies that could

be applied to unmet or under-met customer needs.

• Early Development: Designing a specific formulation, assessing safety, proving

efficacy, defining dosages, and developing an efficient manufacturing process

• Late Development and Registration: Conducting definitive studies on product

efficacy and effectiveness, animal safety, human safety, and environmental

toxicology, and providing other required information (such as product stability

studies) to meet regulatory requirements.

• Support: Providing in-depth technical support for customers, partners, or

regulators, while continuing to evaluate new and better uses for products and

translating learnings from customers back in to the R&D process.

Learn more at elanco.com

15


VETSTEM BIOPHARMA

VetStem Biopharma is a veterinarian-led Regenerative Veterinary Medicine company,

providing stem cells and PRP for Equine and Small Animal veterinarians since 2002.

VetStem pioneered use of adipose stem cells in veterinary medicine and has published

13 peer-reviewed publications supporting evidence-based clinical decisions. VetStem

holds exclusive license rights to over 70 patents for use of adipose-derived stem cells.

VetStem is committed to industry education and offered the first RACE approved

Regenerative Medicine course, taken by over 4,000 veterinarians. In the last decade

over 12,000 animals have been treated using VetStem services and we are committed

to delivering multiple FDA-approved off-the-shelf stem cell products in the near future.

Learn more at vetstem.com

Gold SponsorsALAMO PINTADO

Since its establishment in 1972, Alamo Pintado Equine Medical Center has become one

of the foremost equine clinics in the country and abroad. It combines state-of-the-art

equine hospital facilities and programs such as rehabilitation, teaching, and research

with an outstanding field practice that cares for many of the horses in the Santa Ynez

Valley. Our goal remains to provide the best and most advanced in equine medical

technology, diagnosis, treatment, and care to our patients, and to further the depth of

veterinary knowledge through research. Learn more at alamopintado.com

ANICELL BIOTECH

AniCell extends the ACTIVE life of animals by using regenerative treatments from

amniotic material. You can now treat animals the same day as diagnosis in the field

with fetal amniotic material collected non-invasively during parturition of healthy foals.

Unlike other regenerative treatments like PRP, Bone Marrow or Adipose Stem Cell, his

product does not require invasive harvesting of tissue or the time to culture it, nor does

it require the purchase of equipment to make the product. The EquusCell and CanisCell

brands have a cellular amnion implantable allograph and biological bandages classified

as a medical device used to provide a bioscaffold to regenerate tissue and bone. Learn

more at anicellbiotech.com


16

BIOLIFE SOLUTIONS

BioLife Solutions develops, manufactures, and markets biopreservation media products

and smart shipping containers connected to a cloud-hosted cold chain management

app to improve the quality of delivery logistics for cells, tissues, and organs. The

company’s proprietary HypoThermosol® and CryoStor® solutions are serum and protein-

free; formulated to reduce preservation-induced cell damage and death; and are highly

valued in the biobanking, drug discovery, and regenerative medicine markets. BioLife

enables commercial companies and clinical researchers, significant improvements in

shelf life and post-preservation viability and function of cells, tissues, and organs.

Learn more at biolifesolutions.com

Silver SponsorsARTHREx VET SYSTEMS

Arthrex Vet Systems is a division of Arthrex, Inc. which manufactures over 8,500

products for arthroscopic and minimally invasive orthopaedic surgical procedures.

Arthrex has been a leader in arthroscopic and orthopaedic solutions for over 20

years. Investing in Arthrex products means you have chosen a company committed

to uncompromising quality and constant product innovation while providing you

with the most competent technical customer support in the industry. Learn more at

arthrexvetsystems.com

AVM BIOTECHNOLOGY

AVM Biotechnology is a Seattle-based expert stem cell company creating drugs that

transform repeat and disappointing stem cell injections to single treatments and one

month recovery time for osteoarthritis and tendon repair in the equine market. Visit our

booth to learn about the types of stem cells used, the need for AVM’s lead compound

AugmenStem™ in order to get the most out of equine stem cell treatments, and see

exciting results so far. Learn more at avmbiotech.com

BIOVISION

Biovision is dedicated to providing veterinary practitioners with quality, innovative,

minimally invasive surgical and diagnostics products that are cost effective and enable

better patient care. Biovision is the first to develop a 1.2mm diameter (size of an

18-guage needle) micro-arthroscope system. Our NeedleView arthroscope system is

ultra-portable, technologically advanced, and allows veterinarians with joint anatomy

experience to easily diagnose and create an effective treatment plan for any joint with

just a local block and sedation. Learn more at biovisionvet.com

17


DECHRA

We’re proud to be market innovators in veterinary products and services. Dechra’s

regenerative medicine portfolio includes the original and proven Orthokine® vet irap 10mL

and 60mL devices, which produce ACS (Autologous Conditioned Serum), a cytokine-rich

serum using the horse’s own blood which is then injected into the joint and Osteokine®, a

Platelet Rich Plasma processing device. Learn more at dechra.com

EqCELL THERAPIES

eQcell Therapies® is a regenerative medicine biotech company based on adult and

neonatal equine stem cells. We currently offer simple autologous cell-based therapies

to horse owners at the Ontario Veterinary College, but are focusing on the development

of allogenic cord blood derived mesenchymal stem cell-based products for the global

equine community. Our company is also developing protocols for individual cell banking

cord blood mesenchymal stem cells. Learn more at eqcell.com

OWL MANOR VETERINARY

Owl Manor Veterinary is a medical device company dedicated to soft tissue and joint

preservation of companion animals (equine and canine). We are committed to innovative,

effective, and efficient treatment through a combination of regenerative medicine, point-

of-care autologous biologics, and complimentary technologies. Our Autologous Cellular

Therapy (ACT™) portfolio offers convenience (under 30 minutes), high yield, and clinically

proven effectiveness. Learn more at omveterinary.com

REGENERATIVE MEDICINE FOUNDATION

The Regenerative Medicine Foundation will host the 12th annual World Stem Cell Summit

& RegMed Capital Conference at the Palm Beach County Convention Center, West Palm

Beach, Florida on December 6-9. Equine Regenerative Medicine and more.

Learn more at worldstemcellsummit.com

www.AniCellBiotech.com/info145 S. 79th St. • Suite 13

Chandler, AZ 85226

REPAIR REGENERATE RECOVER

AniCell BrandsAlloMatrixTendons, Ligaments, Joints and other soft tissue injuries

StemWrapHard to heal superficial wounds

AlloOcularEye lesions and corneal ulcers

Human Tested, Animal Approved!AniCell’s regenerative products allow veterinarians to treat tissue injuries in equines and canines the same day as diagnosis. By using an all-natural amniotic bioscaffold, AniCell products give the matrix needed for tissue growth in chronic and acute wounds, joints, tendons/ligaments or eye issues.

www.AniCellBiotech.com/infowww.AniCellBiotech.com/infowww.AniCellBiotech.com/infoneeded for tissue growth in chronic and acute wounds, joints, tendons/ligaments or eye issues.needed for tissue growth in chronic and acute wounds, joints, tendons/ligaments or eye issues.needed for tissue growth in chronic and acute wounds, joints, tendons/ligaments or eye issues.

AniCell’s regenerative products allow veterinarians to treat tissue injuries in equines and canines the same day as diagnosis. By using an all-natural amniotic bioscaffold, AniCell products give the matrix AniCell’s regenerative products allow veterinarians to treat tissue injuries in equines and canines the same day as diagnosis. By using an all-natural amniotic bioscaffold, AniCell products give the matrix same day as diagnosis. By using an all-natural amniotic bioscaffold, AniCell products give the matrix same day as diagnosis. By using an all-natural amniotic bioscaffold, AniCell products give the matrix needed for tissue growth in chronic and acute wounds, joints, tendons/ligaments or eye issues.needed for tissue growth in chronic and acute wounds, joints, tendons/ligaments or eye issues.same day as diagnosis. By using an all-natural amniotic bioscaffold, AniCell products give the matrix AniCell’s regenerative products allow veterinarians to treat tissue injuries in equines and canines the same day as diagnosis. By using an all-natural amniotic bioscaffold, AniCell products give the matrix needed for tissue growth in chronic and acute wounds, joints, tendons/ligaments or eye issues.needed for tissue growth in chronic and acute wounds, joints, tendons/ligaments or eye issues.needed for tissue growth in chronic and acute wounds, joints, tendons/ligaments or eye issues.

Human Tested, Animal Approved!AniCell’s regenerative products allow veterinarians to treat tissue injuries in equines and canines the

Human Tested, Animal Approved!AniCell’s regenerative products allow veterinarians to treat tissue injuries in equines and canines the AniCell’s regenerative products allow veterinarians to treat tissue injuries in equines and canines the same day as diagnosis. By using an all-natural amniotic bioscaffold, AniCell products give the matrix AniCell’s regenerative products allow veterinarians to treat tissue injuries in equines and canines the same day as diagnosis. By using an all-natural amniotic bioscaffold, AniCell products give the matrix same day as diagnosis. By using an all-natural amniotic bioscaffold, AniCell products give the matrix needed for tissue growth in chronic and acute wounds, joints, tendons/ligaments or eye issues.same day as diagnosis. By using an all-natural amniotic bioscaffold, AniCell products give the matrix needed for tissue growth in chronic and acute wounds, joints, tendons/ligaments or eye issues.

AniCell’s regenerative products allow veterinarians to treat tissue injuries in equines and canines the Human Tested, Animal Approved!

AniCell’s regenerative products allow veterinarians to treat tissue injuries in equines and canines the same day as diagnosis. By using an all-natural amniotic bioscaffold, AniCell products give the matrix needed for tissue growth in chronic and acute wounds, joints, tendons/ligaments or eye issues.same day as diagnosis. By using an all-natural amniotic bioscaffold, AniCell products give the matrix same day as diagnosis. By using an all-natural amniotic bioscaffold, AniCell products give the matrix needed for tissue growth in chronic and acute wounds, joints, tendons/ligaments or eye issues.same day as diagnosis. By using an all-natural amniotic bioscaffold, AniCell products give the matrix needed for tissue growth in chronic and acute wounds, joints, tendons/ligaments or eye issues.

www.AniCellBiotech.com/infoneeded for tissue growth in chronic and acute wounds, joints, tendons/ligaments or eye issues.

www.AniCellBiotech.com/infoneeded for tissue growth in chronic and acute wounds, joints, tendons/ligaments or eye issues.needed for tissue growth in chronic and acute wounds, joints, tendons/ligaments or eye issues.same day as diagnosis. By using an all-natural amniotic bioscaffold, AniCell products give the matrix needed for tissue growth in chronic and acute wounds, joints, tendons/ligaments or eye issues.

www.AniCellBiotech.com/infowww.AniCellBiotech.com/info

Human Tested, Animal Approved!AniCell’s regenerative products allow veterinarians to treat tissue injuries in equines and canines the AniCell’s regenerative products allow veterinarians to treat tissue injuries in equines and canines the AniCell’s regenerative products allow veterinarians to treat tissue injuries in equines and canines the AniCell’s regenerative products allow veterinarians to treat tissue injuries in equines and canines the

Human Tested, Animal Approved!Human Tested, Animal Approved!Human Tested, Animal Approved!AniCell’s regenerative products allow veterinarians to treat tissue injuries in equines and canines the same day as diagnosis. By using an all-natural amniotic bioscaffold, AniCell products give the matrix AniCell’s regenerative products allow veterinarians to treat tissue injuries in equines and canines the

Human Tested, Animal Approved!Human Tested, Animal Approved!

www.AniCellBiotech.com/infowww.AniCellBiotech.com/infowww.AniCellBiotech.com/infowww.AniCellBiotech.com/infowww.AniCellBiotech.com/infoneeded for tissue growth in chronic and acute wounds, joints, tendons/ligaments or eye issues.

www.AniCellBiotech.com/info

Human Tested, Animal Approved!Human Tested, Animal Approved!

,145 S. 79th St. • Suite 13145 S. 79th St. • Suite 13

r, AZ 85226145 S. 79th St. • Suite 13

AZ 85226r,

Human Tested, Animal Approved!Human Tested, Animal Approved!Human Tested, Animal Approved!Human Tested, Animal Approved!AniCell’s regenerative products allow veterinarians to treat tissue injuries in equines and canines the AniCell’s regenerative products allow veterinarians to treat tissue injuries in equines and canines the same day as diagnosis. By using an all-natural amniotic bioscaffold, AniCell products give the matrix needed for tissue growth in chronic and acute wounds, joints, tendons/ligaments or eye issues.

145 S. 79th St. • Suite 13needed for tissue growth in chronic and acute wounds, joints, tendons/ligaments or eye issues.

AniCell’s regenerative products allow veterinarians to treat tissue injuries in equines and canines the

needed for tissue growth in chronic and acute wounds, joints, tendons/ligaments or eye issues.145 S. 79th St. • Suite 13

same day as diagnosis. By using an all-natural amniotic bioscaffold, AniCell products give the matrix needed for tissue growth in chronic and acute wounds, joints, tendons/ligaments or eye issues.same day as diagnosis. By using an all-natural amniotic bioscaffold, AniCell products give the matrix needed for tissue growth in chronic and acute wounds, joints, tendons/ligaments or eye issues.needed for tissue growth in chronic and acute wounds, joints, tendons/ligaments or eye issues.

www.AniCellBiotech.com/infoneeded for tissue growth in chronic and acute wounds, joints, tendons/ligaments or eye issues.needed for tissue growth in chronic and acute wounds, joints, tendons/ligaments or eye issues.

AniCell’s regenerative products allow veterinarians to treat tissue injuries in equines and canines the same day as diagnosis. By using an all-natural amniotic bioscaffold, AniCell products give the matrix needed for tissue growth in chronic and acute wounds, joints, tendons/ligaments or eye issues.

clinical trial participationVisit www.avmbiotech.com/partner-with-us for further information or to participate in a clinical trial with your horse or canine companion.

-

Stem™ before stem cell therapy: • Eliminates the need for repeat stem cell injections• Reduces the number of stem cells needed by 10 fold• Improves response rates from 50% to 100%• Accelerates healing from months to weeks

we make stem cells work better.

www.avmbiotech.com

21


Notes



22

Notes

23


Dr. Alan Nixon, Chair

Cornell University

Dr. Jennifer Barrett,

Immediate Past Chair

Virginia Tech University

Dr. Kurt Hankenson, Chair Elect

Michigan State University

Dr. Scott Hopper, Treasurer

Rood & Riddle Equine Hospital

Dr. Thomas G. Koch, Secretary

Ontario Veterinary College

Dr. John Peroni

University of Georgia

Dr. Doug Herthel

Alamo Pintado Equine Medical Center

Dr. Susan W. Volk

University of Pennsylvania

Dr. Tracy Lehman Webb

Colorado State University

NAvrmA Board of Directors

coNfereNce committee MembersDr. Natanya Nieman

Winstar Farm

Dr. Sean Owens

University of California Davis

Dr. Allison Stewart

University of Illinois

For more information about the board of directors, visit the NAVRMA website: http://www.navrma.org/about-navrma/board-of-directors

www.navrma.org

About NAvrmA

As an independent, nonprofit organization, NAVRMA encourages professional improvement and the exchange of knowledge and ideas among people interested in veterinary regenerative medicine. The organization seeks to achieve the following goals:

• Increase the knowledge of veterinary regenerative medicine through encouragement of basic and applied research

• Enhance the professional development of workers in this discipline

• Develop and exchange expertise in veterinary regenerative medicine through periodic meetings and publications

• Encourage and foster collaborative efforts and clinical trials in the field of veterinary regenerative medicine

• Help support research and clinical dissemination of information on veterinary regenerative medicine within North America and beyond

• Encourage training of young veterinarians and research scientists in veterinary regenerative medicine

• Consider and make recommendations on policies and regulations pertaining to veterinary regenerative medicine as necessary

• Interact in an appropriate manner with other scientific organizations as required

2016 north american veterinary regen erative medicine ... · cell use in oa clinical research...

Documents